inhibitor

(redirected from 5-alpha reductase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
See: deterrent
References in periodicals archive ?
All three of the molecules below are 5-alpha reductase inhibitors and prevent testosterone from converting to DHT, the "bad" form of testosterone that causes baldness and prostate issues
A review of several published reports attribute the higher Gleason scores observed in the groups taking the 5-alpha reductase inhibitors (Avodart[R] or Proscar[R]) to the fact that it was easier to find high-grade cancers in the shrunken glands of men taking these drugs compared to the much larger glands of men in the placebo group.
Schellhammer has received research funds or support from GlaxoSmithKline, which markets the 5-alpha reductase inhibitor dutasteride, and from other pharmaceutical companies.
The 5-alpha reductase inhibitors are known to lower levels of dihydrotestosterone, which can contribute to prostate cancer growth.
Finasteride is in a class of medications known as 5-alpha reductase inhibitors (5-ARIs), used to treat benign prostate enlargement (BPH).
Finasteride, marketed as Proscar and the hair-loss drug Propecia, is in a class of drugs known as 5-alpha reductase inhibitors, which are used to treat benign prostatic hyperplasia (BPH, or enlarged prostate).
20) The current approach for medical management of LUTS associated with BPH depends on the usage of alpha-1 receptor blockers, such as alfuzosin, doxazosin, silodosin, tamsulosin and terazosin or suppression of the hormonal growth of the prostate by the 5-alpha reductase inhibitors finasteride and dutasteride.
The two main classes of BPH drugs: alpha blockers like Flomax and UroXatral, which relax the muscles of the bladder neck and prostate, and 5-alpha reductase inhibitors like Proscar and Avodart, which lower levels of hormones produced by the prostate.
For men with significant enlargement, drugs called 5-alpha reductase inhibitors (5-ARIs) are available to shrink the prostate.
Medications known as 5-alpha reductase inhibitors (5-ARIs) do not increase the likelihood of suicide, but they are associated with a greater risk of depression and self-harm, a recent study suggests.
1093/ annonc/mdq695), suggest that men with early baldness may benefit from routine prostate cancer screening or preventive measures that could include the systematic use of 5-alpha reductase inhibitors, the researchers wrote.
The findings suggest that men with early baldness may benefit from routine prostate cancer screening or preventive measures that could include the systematic use of 5-alpha reductase inhibitors, the researchers wrote (doi:10.

Full browser ?